Search research articles
Contact Us
Filters
Showing results (481-490 of 494) with videos related to
Page
of 50
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
<i>In vivo</i> evolution of a <i>Klebsiella pneumoniae</i> capsule defect promotes complement-mediated opsono-phagocytosis and persistence during recurrent infection
William Bain, Brian Ahn, Hernán F Peñaloza, et al.
Open Forum Infectious Diseases
|
November 16, 2022
Clinical Impact of Ceftriaxone Resistance in <i>Escherichia coli</i> Bloodstream Infections: A Multicenter Prospective Cohort Study
Pranita D Tamma, Lauren Komarow, Lizhao Ge, et al.
Mayo Clinic Proceedings
|
October 8, 2016
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
International Journal of Antimicrobial Agents
|
August 8, 2017
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
Patrick N A Harris, M Diletta Pezzani, Belén Gutiérrez-Gutiérrez, et al.
The Lancet. Infectious Diseases
|
April 27, 2017
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
The Journal of Clinical Investigation
|
September 11, 2018
Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium
Haider H Dar, Yulia Y Tyurina, Karolina Mikulska-Ruminska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections
Natalie A Mackow, Wanying Shao, Lizhao Ge, et al.
Antimicrobial Agents and Chemotherapy
|
May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study
Lee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
The Lancet. Infectious Diseases
|
March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin, Cesar A Arias, Lauren Komarow, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2020
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
Yohei Doi, Masaya Hibino, Ryota Hase, et al.
Page
of 50
Search research articles
Search
Showing results (481-490 of 494) with videos related to
Sort By:
Page
of 50
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
<i>In vivo</i> evolution of a <i>Klebsiella pneumoniae</i> capsule defect promotes complement-mediated opsono-phagocytosis and persistence during recurrent infection
William Bain, Brian Ahn, Hernán F Peñaloza, et al.
Open Forum Infectious Diseases
|
November 16, 2022
Clinical Impact of Ceftriaxone Resistance in <i>Escherichia coli</i> Bloodstream Infections: A Multicenter Prospective Cohort Study
Pranita D Tamma, Lauren Komarow, Lizhao Ge, et al.
Mayo Clinic Proceedings
|
October 8, 2016
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
International Journal of Antimicrobial Agents
|
August 8, 2017
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
Patrick N A Harris, M Diletta Pezzani, Belén Gutiérrez-Gutiérrez, et al.
The Lancet. Infectious Diseases
|
April 27, 2017
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
The Journal of Clinical Investigation
|
September 11, 2018
Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium
Haider H Dar, Yulia Y Tyurina, Karolina Mikulska-Ruminska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections
Natalie A Mackow, Wanying Shao, Lizhao Ge, et al.
Antimicrobial Agents and Chemotherapy
|
May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study
Lee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
The Lancet. Infectious Diseases
|
March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin, Cesar A Arias, Lauren Komarow, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2020
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
Yohei Doi, Masaya Hibino, Ryota Hase, et al.
Page
of 50